Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Alcohol Clin Exp Res. 2020 Jan 13;44(2):553–566. doi: 10.1111/acer.14269

Figure 2.

Figure 2.

PPAR agonists, tesaglitazar and fenofibrate, did not alter ethanol intake in a two bottle choice (2BC) assay with male HDID-1and HS/NPT mice. 2BC testing offered 3-10% ethanol (Days 1-7) and 15% ethanol on Days 8-31. Drugs were administered daily on Days 24-31; average daily intakes from Days 24-31 are shown (Mean ± SEM). A) 24-hr ethanol intake. B) 6 hr intake. n=9-12 mice/line/treatment dose.